naltrexone has been researched along with codeine in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (27.03) | 18.7374 |
| 1990's | 7 (18.92) | 18.2507 |
| 2000's | 11 (29.73) | 29.6817 |
| 2010's | 9 (24.32) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheney, BV | 1 |
| Bousquet, AR; Howes, JF; Kotick, MP; Leland, DL; Polazzi, JO | 1 |
| Adapa, ID; Auh, JS; Berzetei-Gurske, IP; Brandt, SR; Craymer, K; Farrington, L; Haggart, D; Kennedy, JM; O'Brien, A; Polgar, WE; Rodriguez, L; Schwartz, RW; Toll, L; White, A | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Chang, TK; Ensom, MH; Kiang, TK | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Aceto, MD; Coop, A; Harris, LS; May, EL; Metcalf, MD; Traynor, JR; Woods, JH | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Dalvie, D; Loi, CM; Smith, DA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brockmöller, J; Friesacher, HR; Meyer, MJ; Neumann, VE; Tzvetkov, MV; Zdrazil, B | 1 |
| Gehrmann, JE; Killam, KF | 1 |
| Carino, MA; Horita, A; Yamawaki, S | 1 |
| Carino, MA; Chinn, C; Horita, A | 1 |
| Mansour, A; Valenstein, ES | 1 |
| Ferreira, SH; Follenfant, RL; Smith, TW | 1 |
| Coale, EH; Hein, DW; Herling, S; Valentino, RJ; Woods, JH | 1 |
| Herling, S | 2 |
| Erenberg, G; Fogelson, MH; McConville, BJ; Norman, AB | 1 |
| Eccles, R; Hutchings, HA | 1 |
| Barasch, A; Cooper, SA; Hersh, EV; MacAfee, K; Ochs, H; Quinn, P | 1 |
| Cutler, R; Fishbain, DA; Rosomoff, HL | 1 |
| Manfredi, B; Mantegazza, P; Panerai, AE; Sacerdote, P | 1 |
| Hirtl, C; Pfab, R; Zilker, T | 1 |
| Hensel, M; Kox, WJ | 1 |
| Cook, DB; O'Connor, PJ; Ray, CA | 1 |
| Ott, J | 1 |
| Luger, P; Messerschmidt, M; Morgenroth, W; Paulmann, C; Scheins, S | 1 |
| Burton, DD; Busciglio, I; Camilleri, M; Manabe, N; McKinzie, S; Rao, AS; Ryks, M; Wong, BS; Zinsmeister, AR | 1 |
| Farré-Albaladejo, M; Fernández-Nieva, Z; Gascón-Crespí, I; Hernández, RM; Igartua, M; Moreno-Vicente, R; Navarro, A; Pedraz, JL | 1 |
| Donnerstag, N; Lüthi, A; Mehlig, A; Raetz Bravo, A; Schneider, T; Taegtmeyer, A | 1 |
| Jiang, GH; Lv, XF; Ma, XF; Qiu, YW; Su, HH; Tian, JZ; Zhuo, FZ | 1 |
| Abdossalami Asl, Y; Karami, M; Rezazadeh, M; Yamini, Y | 1 |
4 review(s) available for naltrexone and codeine
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Opiate detoxification protocols. A clinical manual.
Topics: Administration, Cutaneous; Clinical Protocols; Clonidine; Codeine; Female; Humans; Male; Methadone; Naloxone; Naltrexone; Opioid-Related Disorders; Psychiatric Status Rating Scales; Receptors, Opioid; Substance Withdrawal Syndrome | 1993 |
5 trial(s) available for naltrexone and codeine
| Article | Year |
|---|---|
The opioid agonist codeine and antagonist naltrexone do not affect voluntary suppression of capsaicin induced cough in healthy subjects.
Topics: Adolescent; Adult; Capsaicin; Codeine; Cough; Endorphins; Female; Humans; Male; Middle Aged; Naltrexone | 1994 |
Narcotic receptor blockade and its effect on the analgesic response to placebo and ibuprofen after oral surgery.
Topics: Adult; Analysis of Variance; Chi-Square Distribution; Codeine; Double-Blind Method; Drug Synergism; Endorphins; Female; Humans; Ibuprofen; Male; Naltrexone; Pain Measurement; Pain, Postoperative; Placebo Effect; Preanesthetic Medication; Receptors, Opioid; Time Factors; Tooth Extraction | 1993 |
Opiate detoxification under anesthesia: no apparent benefit but suppression of thyroid hormones and risk of pulmonary and renal failure.
Topics: Acute Kidney Injury; Adult; Anesthesia; Codeine; Female; Heroin Dependence; Humans; Male; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Respiratory Insufficiency; Substance Withdrawal Syndrome; Thyroid Hormones | 1999 |
Muscle pain perception and sympathetic nerve activity to exercise during opioid modulation.
Topics: Adolescent; Adult; Blood Pressure; Codeine; Exercise; Hand Strength; Heart Rate; Humans; Male; Muscle, Skeletal; Naltrexone; Opioid Peptides; Pain; Pain Threshold; Perception; Placebos; Sympathetic Nervous System | 2000 |
The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health.
Topics: Adolescent; Adult; Analgesics, Opioid; Codeine; Double-Blind Method; Drug Combinations; Female; Gastrointestinal Tract; Gastrointestinal Transit; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Quaternary Ammonium Compounds; Receptors, Opioid, mu; Young Adult | 2010 |
28 other study(ies) available for naltrexone and codeine
| Article | Year |
|---|---|
Structure-activity relationships for drugs binding to the agonist and antagonist states of the primary morphine receptor.
Topics: Algorithms; Animals; Kinetics; Models, Molecular; Narcotic Antagonists; Narcotics; Protein Conformation; Rats; Receptors, Opioid; Structure-Activity Relationship | 1988 |
Analgesic narcotic antagonists. 8. 7 alpha-Alkyl-4,5 alpha-epoxymorphinan-6-ones.
Topics: Analgesics; Animals; Chemical Phenomena; Chemistry; Codeine; Hydrocodone; In Vitro Techniques; Mice; Narcotic Antagonists; Rats; Reaction Time | 1981 |
Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.
Topics: Animals; Aorta, Thoracic; Cocaine; Cyclic AMP; Electric Stimulation; Guinea Pigs; Humans; Ileum; In Vitro Techniques; Male; Mice; Muscle, Smooth; Opioid-Related Disorders; Rats; Receptors, Dopamine; Receptors, Opioid; Receptors, Serotonin; Substance-Related Disorders | 1998 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans.
Topics: Analgesics, Opioid; Benzomorphans; Carboxylic Acids; Esters; Molecular Structure; Stereoisomerism; Structure-Activity Relationship | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1.
Topics: Analgesics, Opioid; HEK293 Cells; Humans; Inhibitory Concentration 50; Models, Molecular; Organic Cation Transporter 1; Permeability; Protein Conformation | 2019 |
Assessment of CNS drug activity in rhesus monkeys by analysis of the EEG.
Topics: Amobarbital; Animals; Brain; Clorazepate Dipotassium; Codeine; Computers; Electroencephalography; Glutethimide; Haplorhini; Macaca mulatta; Morphine; Nalbuphine; Naloxone; Naltrexone | 1976 |
Analeptic effect of opiate receptor agonists in rabbits.
Topics: Animals; Arousal; Brain; Central Nervous System Stimulants; Codeine; Cyclazocine; Dose-Response Relationship, Drug; Enkephalin, Methionine; Ethylketocyclazocine; Etorphine; Male; Meperidine; Methadone; Morphine; Naltrexone; Narcotics; Phenazocine; Rabbits; Receptors, Opioid; Reflex | 1985 |
Codeine produces a cholinergically mediated analeptic effect in rats and rabbits.
Topics: Animals; Brain; Central Nervous System Stimulants; Choline; Codeine; Diazepam; Drug Interactions; Male; Naltrexone; Pentobarbital; Rabbits; Rats; Rats, Inbred Strains; Synaptosomes | 1988 |
Changes in responsiveness to mu and kappa opiates following a series of convulsions.
Topics: Animals; Codeine; Dose-Response Relationship, Drug; Electroshock; Levorphanol; Mice; Mice, Inbred C57BL; Morphine; Naltrexone; Narcotics; Receptors, Opioid; Seizures | 1985 |
Antinociceptive models displaying peripheral opioid activity.
Topics: Analgesics; Animals; Carrageenan; Codeine; Dextropropoxyphene; Dose-Response Relationship, Drug; Epoprostenol; Female; Indomethacin; Mice; Morphine; Movement; Nalorphine; Naloxone; Naltrexone; Narcotic Antagonists | 1985 |
Narcotic discrimination in pigeons.
Topics: Animals; Clonidine; Codeine; Columbidae; Cyclazocine; Discrimination Learning; Dose-Response Relationship, Drug; Ethylketocyclazocine; Ketamine; Meperidine; Morphine; Nalorphine; Naltrexone; Narcotics; Pentazocine; Pentobarbital; Species Specificity | 1980 |
Effects of naltrexone dose and history of naltrexone exposure on food- and codeine-maintained responding in rhesus monkeys.
Topics: Animals; Codeine; Conditioning, Operant; Dose-Response Relationship, Drug; Food; Macaca mulatta; Naloxone; Naltrexone; Reaction Time | 1981 |
Naltrexone effects on food-and codeine-maintained responding in rhesus monkeys.
Topics: Animals; Behavior, Animal; Codeine; Conditioning, Operant; Dose-Response Relationship, Drug; Food; Macaca mulatta; Naloxone; Naltrexone; Reinforcement, Psychology; Self Administration | 1981 |
Sequential use of opioid antagonists and agonists in Tourette's syndrome.
Topics: Adult; Codeine; Drug Administration Schedule; Female; Humans; Male; Naltrexone; Tourette Syndrome | 1994 |
Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study.
Topics: Animals; Cell Division; Codeine; Hydromorphone; Immune System; Immunosuppression Therapy; Interleukin-2; Male; Mice; Morphine; Nalorphine; Naloxone; Naltrexone; Narcotics; Oxycodone; Structure-Activity Relationship | 1997 |
Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.
Topics: Adult; Anesthesia, General; Codeine; Female; Heroin Dependence; Humans; Male; Methadone; Morphine Dependence; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Prospective Studies; Substance Withdrawal Syndrome | 2000 |
Obviation of opioid withdrawal syndrome by concomitant administration of naltrexone in microgram doses: two psychonautic bioassays.
Topics: Codeine; Half-Life; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome | 2006 |
Electron density analyses of opioids: a comparative study.
Topics: Analgesics, Opioid; Codeine; Cold Temperature; Dextromethorphan; Diprenorphine; Electrons; Models, Molecular; Morphine; Naltrexone; X-Ray Diffraction | 2007 |
Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxo
Topics: Administration, Oral; Calibration; Chromatography, Liquid; Codeine; Formates; Healthy Volunteers; Heroin; Humans; Hydrogen-Ion Concentration; Limit of Detection; Morphine; Naloxone; Naltrexone; Quality Control; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection; Tandem Mass Spectrometry | 2015 |
Severe opioid withdrawal syndrome after a single dose of nalmefene.
Topics: Adult; Alcoholism; Analgesics, Opioid; Codeine; Contraindications; Drug Interactions; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2015 |
Short-term UROD treatment on cerebral function in codeine-containing cough syrups dependent male individuals.
Topics: Adult; Anesthesia, General; Antitussive Agents; Brain; Brain Mapping; Codeine; Humans; Magnetic Resonance Imaging; Male; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Prospective Studies; Substance Withdrawal Syndrome; Treatment Outcome; Young Adult | 2016 |
On-chip pulsed electromembrane extraction as a new concept for analysis of biological fluids in a small device.
Topics: Blood Chemical Analysis; Codeine; Electrochemistry; Electrodes; Humans; Limit of Detection; Liquid-Liquid Extraction; Membranes, Artificial; Naloxone; Naltrexone; Solvents; Urinalysis | 2017 |